EBITDA Margin
-126.97%
TTM · Period ending:
MRNA EBITDA Margin
Latest reported-126.97%period ending
Latest reported-126.97%period ending
MRNA TTM EBITDA Margin (-120.89% → -126.97%)
TTM ebitda margin
High-resolution chart · PNG
MRNA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -126.9749% | |
| -129.6629% | |
| -131.2918% | |
| -132.2377% | |
| -88.9869% | |
| -101.784% | |
| -106.0957% | |
| -39.5174% | |
| -75.0397% | |
| -81.2415% | |
| -48.0955% | |
| -19.821% | |
| 11.5724% | |
| 36.6886% | |
| 52.6834% | |
| 66.2007% | |
| 71.6882% | |
| 75.489% | |
| 76.2799% | |
| 68.5101% | |
| 58.8301% | |
| 27.1897% | |
| -87.5002% | |
| -225.6334% | |
| -424.9204% | |
| -892.8347% | |
| -794.1687% | |
| -609.3399% | |
| -429.398% | |
| -339.7226% | |
| -265.0672% | |
| -136.5438% | |
| -130.2569% | |
| -120.9862% | |
| -120.8886% |